#151084

Anti-HPV16L1 [CamVir 1]

Cat. #151084

Anti-HPV16L1 [CamVir 1]

Cat. #: 151084

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: Human papilloma virus type 16, major capsid protein L1 (HPV16 L1)

Class: Monoclonal

Application: ELISA ; IHC ; IP ; WB

Reactivity: Human papilloma virus

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Lawrence Banks

Institute: University of Cambridge

Tool Details
Target Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-HPV16L1 [CamVir 1]
  • Cancer: Gynaecologic cancer
  • Cancers detailed: Cervical
  • Research fields: Cancer;Microbiology
  • Clone: CamVir 1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 56 kDa
  • Strain: Balb/c
  • Reactivity: Human papilloma virus
  • Host: Mouse
  • Application: ELISA ; IHC ; IP ; WB
  • Description: The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases, and HPV-1, which is associated with benign cutaneous warts. HPV late protein L1 is the major capsid protein.
  • Immunogen: A b galactosidase-L1 fusion protein purified by PAGE.
  • Isotype: IgG2a
  • Myeloma used: NS0

Target Details

  • Target: Human papilloma virus type 16, major capsid protein L1 (HPV16 L1)
  • Molecular weight: 56 kDa
  • Target background: The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases, and HPV-1, which is associated with benign cutaneous warts. HPV late protein L1 is the major capsid protein.

Applications

  • Application: ELISA ; IHC ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: '-15° C to -25° C
  • Shipping conditions: Shipping at 4° C

Related Tools

  • Related tools: Anti-HPV16E6 & HPV18E6, Recombinant [C1P5]

References

  • Day et al. 2012. Clin Vaccine Immunol. 19(7):1075-82. PMID: 22593236.
  • A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.
  • Steele et al. 2005. Br J Cancer. 93(2):248-59. PMID: 15986031.
  • T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.
  • Zhang et al. 1998. Virology. 243(2):423-31. PMID: 9568041.
  • Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro.
  • McLean et al. 1990. J Clin Pathol. 43(6):488-92. PMID: 2166093.
  • Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus.